Anti-fibrotic Drug Shows Promise in Breast Cancer Treatment
The most prevalent type of breast cancer is known as HER2-negative breast cancer, so named because it has low levels
Read MoreThe most prevalent type of breast cancer is known as HER2-negative breast cancer, so named because it has low levels
Read MoreAge, public insurance status, lack of insurance, comorbidities, nonmetastatic illness, lower tumor grade, and being older are associated with racial
Read MoreAn artificial intelligence (AI) tool created by a group of international researchers can identify breast cancer treatment patients who may
Read MoreIn a study reported in The Lancet Oncology, researchers from the Mayo Clinic Comprehensive Cancer Center found that breast cancer
Read MoreThe survival rate for breast cancer in its initial stages is almost 100%. However, that incidence lowers to about 25%
Read MoreResearchers from Georgetown University’s Lombardi Comprehensive Cancer Center collaborated with scientists from the University of Miami, Florida, to discover how
Read MoreAccording to recent CU Boulder research, cancer cells are smarter than scientists previously thought. When these cells are met with
Read MoreResearchers at the Vera Bradley Foundation Center for Breast Cancer Research at Indiana University Melvin and Bren Simon Comprehensive Cancer
Read MoreAmong women who identified as Black/African American or Hispanic/Latina, those with low blood levels of vitamin D were more likely
Read More